Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Feb 28, 2023, after the close
10-K filed Feb 28, 2023, 59 days after period end · 0001104659-23-026701
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $1.61M | $333.00K | $3.79M | $887.00K |
| EPS Diluted | — | — | -$0.55 |
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
| -$0.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.